Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...
DUBLIN--(BUSINESS WIRE)--The "Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Inhalation and ...
Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...
Lundbeck reported solid year-end results, highlighted by 2023 revenue of DKK 19.9 billion, representing 9% growth from 2022. Continued strong performance from Lundbeck’s strategic brands (Rexulti, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback